Author: franperez66q@protonmail.com

Why is AlzChem stock surging today? Source link

Jensen Huang, chief executive officer of Nvidia Corp., speaks at the Nvidia GTC conference on the sidelines of Computex 2026 in Taipei, Taiwan, on Monday, June 1, 2026. Lam Yik Fei | Bloomberg | Getty ImagesNvidia’s CEO Jensen Huang hailed this chip designer as the next trillion-dollar firm, sending its shares up sharply in premarket trading Tuesday. Marvell Technology, a semiconductor firm that designs chips for data centers, soared after Huang touted the company’s efforts in supplying the AI infrastructure build-out during an onstage appearance with Marvell CEO Matthew Murphy at Computex Week in Taipei on Monday.The stock was last…

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.It sometimes takes years to get “good”, “correct” figures for UK growth, so FT Alphaville is going to be gentle towards the soft animal of our body for being a week late to an interesting analysis by James Rossiter of TD Securities:[S]peculation has risen that there is a growing issue with the [Office for National Statistics]’ seasonal factors in recent years, resulting in an over-stating of H1 GDP growth and an under-stating in H2 growth (seasonal factors don’t affect the year as…

U.S. Treasury yields fell on Tuesday, following global yields lower, as President Trump’s announcement of a ceasefire between Iran-backed Hezbollah and Israel bolsters investor sentiment.The yield on the 10-year U.S. Treasury note — the key benchmark for U.S. government borrowing — fell more than 4 basis points to 4.434%.The 2-year Treasury note yield, which more closely tracks short-term Federal Reserve interest rate policy, fell more than 3 basis points to 4.018%. The longer-dated 30-year Treasury bond yield fell more than 3 basis points to 4.956%. One basis point is equal to 0.01%, and yields and prices move in opposite directions.Global bond…

STMicroelectronics to decide on Crolles fab expansion by year-end Source link

Altman accused of making ChatGPT unsafe The lawsuit joins prior suits accusing Altman of callously deploying AI systems without regard for user safety. In his complaint, Uthmeier recalled how Altman told TED2025 attendees that right now “the stakes are relatively low” for OpenAI to safety-test its products on real users, which he claimed is the only way to iteratively improve them. “But the stakes aren’t low,” Uthmeier said. “Floridians—including our vulnerable children—have suffered monetary loss, mental health harms, cognitive decline, and physical harm from Defendants’ deceptive, unethical, and recklessly dangerous conduct. Defendants must be held accountable for the harm they…

FedEx Freight CEO John Smith said on Monday the company’s separation from FedEx will allow it to invest more aggressively in growth initiatives and better compete in the less-than-truckload shipping market.”The things that we are going to be able to control now, especially from a capital and investment perspective, be able to put dollars into the LTL company that are LTL specific … That’s going to help us leapfrog the competitors,” Smith said on CNBC’s “Mad Money.” FedEx Freight began trading as an independent company Monday after being spun off from FedEx. The company is the largest less-than-truckload (LTL) carrier…

Chemring stock down after profit decline offsets record order book Source link

The worm, dubbed Shai-Hulud, has all the hallmarks of malware released last month as freely available open source. TeamPCP was the first group to use Shai-Hulud, and it promoted a competition that promised a $1,000 payment to the hacker who carried out the biggest supply-chain attack using the malware. TeamPCP has also been behind a rash of previous supply-chain attacks. Now that the worm is in the hands of many other threat groups, supply-chain attacks may ramp up further. The malware devotes considerable attention to CI/CD (continuous integration/continuous delivery) systems, which allow for faster and more reliable software releases by…

Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug for ulcerative colitis.The medicine met its endpoints of demonstrating a clinically meaningful efficacy and a remission rate of about 40% for both doses tested, but also showed that there were cancer cases among patients taking the higher dose.Abivax said the cancer cases were considered “unrelated to treatment by investigators, and no organ-specific clustering was observed.””[The] cancer signal complicates matters,” a Jefferies analyst said. “Even if unrelated noise, we think the overhang will be real, especially considering absence of other value-inflecting…